Next Article in Journal
Construction and Evaluation of an Efficient Live Attenuated Salmonella Choleraesuis Vaccine and Its Ability as a Vaccine Carrier to Deliver Heterologous Antigens
Next Article in Special Issue
Analysis of the Presence and Levels of IgG Antibodies Directed against the S1 Protein Receptor Binding Domain and the N Protein of SARS-CoV-2 in Patients with Multiple Sclerosis Treated with Immunomodulatory Therapies
Previous Article in Journal
Hybrid Immunity Improves the Immune Response after the Fourth COVID-19 Vaccine Dose in Individuals with Medical Conditions Predisposing to Severe COVID-19
Previous Article in Special Issue
Long-Term Immunogenicity and Safety of a Homologous Third Dose Booster Vaccination with TURKOVAC: Phase 2 Clinical Study Findings with 32-Week Post-Booster Follow-Up
 
 
Brief Report

Article Versions Notes

Vaccines 2024, 12(3), 248; https://doi.org/10.3390/vaccines12030248
Action Date Notes Link
article xml file uploaded 27 February 2024 09:43 CET Original file -
article xml uploaded. 27 February 2024 09:43 CET Update https://www.mdpi.com/2076-393X/12/3/248/xml
article pdf uploaded. 27 February 2024 09:43 CET Version of Record https://www.mdpi.com/2076-393X/12/3/248/pdf
article html file updated 27 February 2024 09:45 CET Original file https://www.mdpi.com/2076-393X/12/3/248/html
Back to TopTop